This study aims to verify whether peripheral blood circulating cells show any absolute quantitative differences between patients with an active tumor inflammatory microenvironment (TIME), marked by PD-L1 expression and/or the presence of tumor-infiltrating lymphocytes (TILs), and those with a silent immune profile, acting as a biochemical marker of an activated adaptive immune surveillance. This evidence concerns the gene CD274 and neoplasm.